Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
3
Next >
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
Tags
Investing
Business News
U/S/ Markets
From
CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
NVIDIA Corp
Markets
Stock Picks
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
Roche Holding AG
Cerevel Therapeutics Holdings Inc
JPMORGAN DRN
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
JPMORGAN DRN
Investment strategy
Novartis AG
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Politics
Prescription drugs
Bristol/Myers Squibb Co
From
CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
December 22, 2023
Tags
Science
Health care industry
Karuna Therapeutics Inc
From
CNBC.com News
Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios
December 18, 2023
Tags
Rite Aid Corp
General Mills Inc
Investing
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
Seagen Inc
Bristol/Myers Squibb Co
Pfizer Inc
From
CNBC.com News
Jim Cramer explains why it's hard to be bullish on the healthcare sector
November 30, 2023
Tags
Cigna Corp
Mad Money
Johnson & Johnson
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
CNBC Investing Club: Newsletter
CNBC Investing Club: Analysis
Sanofi SA
From
CNBC.com News
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
October 26, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Cramer's Lightning Round: Sell Fisker
October 23, 2023
Tags
stocks
Stock markets
Nu Holdings Ltd
From
CNBC.com News
5 things to know before the stock market opens Monday
October 23, 2023
Tags
Politics
Investment strategy
Pioneer Natural Resources Co
From
CNBC.com News
Top Wall Street analysts favor these five dividend stocks during tumultuous times
October 22, 2023
Tags
EOG Resources Inc
U/S/ Markets
Investing
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Business News
Health & Science
AstraZeneca PLC
From
CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
Tags
Pharmaceuticals
Business
Breaking news
From
CNBC.com News
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
September 27, 2023
Tags
Health care industry
Johnson & Johnson
Biotech and Pharmaceuticals
From
CNBC.com News
Top Wall Street analysts are bullish on these dividend stocks
September 24, 2023
Tags
U/S/ Markets
Southern Co
Public Service Enterprise Group Inc
From
CNBC.com News
Judge withdraws from Medicare drug price case after stock ownership is revealed
September 01, 2023
Tags
Biotech and Pharmaceuticals
Merck & Co Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
Tags
Beigene Ltd
Politics
Bristol/Myers Squibb Co
From
CNBC.com News
5 things to know before the stock market opens Wednesday
August 30, 2023
Tags
Apple Inc
Technology
Coinbase Global Inc
From
CNBC.com News
Here are the three most used drugs on the Medicare price negotiation list
August 29, 2023
Tags
Johnson & Johnson
Health care industry
Bristol/Myers Squibb Co
From
CNBC.com News
Biden administration unveils first 10 drugs subject to Medicare price negotiations as it moves to cut costs
August 29, 2023
Tags
Astellas Pharma Inc
Pharmaceuticals
Business
From
CNBC.com News
Why startups are investing millions to make drugs and semiconductors in space
August 20, 2023
Tags
Technology
Mobile
Redwire Corp
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Business
Abbvie Inc
Astellas Pharma Inc
From
CNBC.com News
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
July 18, 2023
Tags
Policy
Johnson & Johnson
Health care industry
From
CNBC.com News
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
June 30, 2023
Tags
Policy
Health care industry
U/S/ Economy
From
CNBC.com News
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
June 21, 2023
Tickers
LAW
LAWS
Tags
Business
Pharmaceuticals
Lawsuits
From
CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
June 20, 2023
Tags
Breaking News: Business
US Economy
Epidemics
From
CNBC.com News
As the market starts to cool down, Cramer says don't be afraid to stay bullish
June 03, 2023
Tags
Business News
U/S/ Markets
Investing
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.